Skip to main content
VCbacked
Log inGet Started

BioHybrid Solutions

Pittsburgh, United States

BioHybrid Solutions is a transformational platform company that develops next-generation nanoarmored protein-polymer conjugates.

$200K raised
Dec 2023
Seed
BiotechnologyNanotechnologyWellness

Top Investors

National Science FoundationInnovation WorksCreative Destruction Lab (CDL)

Founder Contacts

19,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about BioHybrid Solutions

How much funding has BioHybrid Solutions raised?
BioHybrid Solutions has raised $200K in total funding. The most recent round was Seed. The last funding was announced in December 2023.
Who are BioHybrid Solutions's investors?
BioHybrid Solutions's investors include National Science Foundation, Innovation Works, Creative Destruction Lab (CDL).
Where is BioHybrid Solutions headquartered?
BioHybrid Solutions is headquartered in Pittsburgh, United States.
What does BioHybrid Solutions do?
BioHybrid Solutions is a transformational platform company that develops next-generation nanoarmored protein-polymer conjugates.
What stage is BioHybrid Solutions at?
BioHybrid Solutions is at the Seed stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"BioHybrid Solutions — Funding & Investors." VCBacked, December 21, 2023, https://www.vcbacked.co/company/biohybrid-solutions. Accessed June 12, 2026.
APA
VCBacked. (2023). BioHybrid Solutions — Funding & Investors. Retrieved June 12, 2026, from https://www.vcbacked.co/company/biohybrid-solutions
Wikipedia (cite web)
{{cite web |title=BioHybrid Solutions — Funding & Investors |url=https://www.vcbacked.co/company/biohybrid-solutions |website=VCBacked |access-date=June 12, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Biotechnology

View all
Virtuoso Surgical
Nashville
Pharvaris
Zug
Odyssey Therapeutics
Boston$213.0M
Tempus
Chicago
Anagram Therapeutics
Boston
Prenetics
Hong Kong